We discuss the non-thermal phase structure of a chirally invariant Higgs-Yukawa model on the lattice in the presence of a higher dimensional 6 -term. For the exploration of the phase diagram we use analytical, lattice perturbative calculations of the constraint effective potential as well as numerical simulations. We also present first results of the effects of the 6 -term on the lower Higgs boson mass bounds.
We derive finite-size scaling formulae for four-dimensional Higgs-Yukawa models near the Gaussian fixed point. These formulae will play an essential role in future, detailed investigation of such models. In particular, they can be used to determine the nature of the observed phase transitions, and confirm or rule out the possibility of having non-trivial fixed points in the Higgs-Yukawa models. Our scaling formula for Binder's cumulant is tested against lattice simulations carried out at weak couplings, and good agreement is found. As a separate project, we also present preliminary results from our study of a chirally-invariant Higgs-Yukawa model including a dimension-six operator at finite temperature. Our work provides first indications of first-order temperature-induced phase transitions near the infinite cutoff limit in this model.
Abstract. We present results from two projects on lattice calculations for the HiggsYukawa model. First we report progress on the search of first-order thermal phase transitions in the presence of a dimension-six operator, with the choices of bare couplings that lead to viable phenomenological predictions. In this project the simulations are performed using overlap fermions. Secondly, our study for applying finite-size scaling techniques near the Gaussian fixed point of the Higgs-Yukawa model is presented. We discuss the analytical formulae for the Higgs Yukawa model and show results for a first numerical study in the pure O(4) scalar sector of the theory.
We analyse finite-size scaling behaviour of a four-dimensional Higgs-Yukawa model near the Gaussian infrared fixed point. Through improving the mean-field scaling laws by solving one-loop renormalisation group equations, the triviality property of this model can be manifested in the volume-dependence of moments of the scalar-field zero mode. The scaling formulae for the moments are derived in this work with the inclusion of the leading-logarithmic corrections. To test these formulae, we confront them with data from lattice simulations in a simpler model, namely the O(4) pure scalar theory, and find numerical evidence of good agreement. Our results of the finite-size scaling can in principle be employed to establish triviality of Higgs-Yukawa models, or to search for alternative scenarios in studying their fixed-point structure, if sufficiently large lattices can be reached.
We investigate the impact of a λ 6 ϕ 6 term included in a chirally invariant lattice Higgs-Yukawa model. Such a term could emerge from BSM physics at some larger energy scale. We map out the phase structure of the Higgs-Yukawa model with positive λ 6 and negative quartic self coupling of the scalar fields. To this end, we evaluate the constraint effective potential in lattice perturbation theory and also determine the magnetization of the model via numerical simulations which allow us to reach also non-perturbative values of the couplings. As a result, we find a complex phase structure with first and second order phase transitions identified through the magnetization. Further we analyze the effect of such a ϕ 6 term on the lower Higgs boson mass bound to see, whether the standard model lower mass bound can be altered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.